Atlas Trials

Trial of High-Dose Rifampin in Patients With TB

Clinical trial NCT01408914 · COMPLETED

Trial details

NCT number
NCT01408914
Sponsor
Harvard University Faculty of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Tuberculosis
Start date
2013-09-01
Primary completion
2016-04-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.